Agios Pharmaceuticals (AGIO) Current Deferred Tax Assets (2012 - 2013)
Agios Pharmaceuticals' (AGIO) quarterly Current Deferred Tax Assets came in at $1.2 million in Q3 2013, little changed on a QoQ basis from $1.2 million in Q2 2013.
Analysis
Agios Pharmaceuticals (AGIO) Current Deferred Tax Assets (2012 - 2013) Analysis & Trends
Agios Pharmaceuticals (AGIO) has 2 years of Current Deferred Tax Assets data on file, last reported at $1.2 million in Q3 2013.
- Quarterly Current Deferred Tax Assets changed N/A year-over-year to $1.2 million in Q3 2013, while the trailing twelve-month figure through Sep 2013 was $1.2 million (changed N/A YoY) and the FY2012 annual result came in at $1.2 million, changed N/A from the prior year.
- Current Deferred Tax Assets steadied at $1.2 million in Q3 2013, from $1.2 million in the prior quarter.
- In the past five years, Current Deferred Tax Assets ranged from a high of $1.2 million in Q2 2013 to a low of $1.2 million in Q4 2012.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 10 | Agios Pharmaceuticals | 1.97 Bn | 1.97 Bn | 41.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2013 | 1.25 Mn |
| Jun 30, 2013 | 1.25 Mn |
| Dec 31, 2012 | 1.25 Mn |